PLOSopen access
Post-market surveillance of albendazole tablet brands in Kenya: Implications for deworming programs and clinical outcomes
helminthic therapy, antimicrobial resistance, low and middle income countries, helminthic therapy, medical risk factors, helminthic therapy
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 285438
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.